Retrospective Analysis of Coronavirus SARS-CoV-2 Antibody Levels in COVID-19 Convalescent Plasma From Blood Donors

Retrospective Analysis of Coronavirus SARS-CoV-2 Antibody Levels in COVID-19 Convalescent Plasma From Blood Donors

Conclusions: There are individual differences in plasma antibody titers among convalescent patients. Antibody detection is helpful for screening out plasma with high antibody titers for the treatment of patients with severe disease.

Saved in:

Bibliographic Details
Main Authors:	Ji He, Yanjun Zhang, Jie Dong, Wei Zhang, Faming Zhu
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:	http://dx.doi.org/10.1155/cjid/4366502
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anti-SARS-CoV-2 antibody responses in convalescent plasma donors with varying severity of COVID-19 illness
by: Grujić Jasmina, et al.
Published: (2022-01-01)

The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2
by: Andy Kwan Pui Chan, et al.
Published: (2025-07-01)

Clinical efficacy and safety of convalescent plasma therapy for patients with SARS-CoV-2 infection
by: D. V. Lavrenchuk, et al.
Published: (2022-04-01)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Keneth Iceland, Kasozi
Published: (2021)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed, Moubarak, et al.
Published: (2023)

Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina.
by: Diego S Ojeda, et al.
Published: (2021-01-01)

Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection
by: Parastoo Hosseini, et al.
Published: (2021-03-01)

Total antibodies and neutralizing ability of convalescent sera against three different strains of SARS-CoV-2
by: Natalia V. Palyanova, et al.
Published: (2025-03-01)

Cumulative seroprevalence of SARS-CoV-2 antibodies among blood donors in Burkina Faso, April 2022
by: Salam Sawadogo, et al.
Published: (2025-03-01)

Novel protocol for selection of SARS-CoV2 convalenscent plasma donors
by: Ostojić Gordana, et al.
Published: (2022-01-01)

Distinct immune memory induced by SARS-CoV-2 in convalescent liver transplant recipients
by: Mengcheng Liu, et al.
Published: (2025-04-01)

Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis.
by: Helen R Savage, et al.
Published: (2021-07-01)

Persistence of SARS-CoV-2-IgG antibody durability in convalescent COVID-19 patients 6 months after the natural infection
by: Qiaoli Hua, et al.
Published: (2025-08-01)

Correction: IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi.
by: Muhammad Hasan, et al.
Published: (2024-01-01)

SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics
by: Nadia Siles Alvarado, et al.
Published: (2025-05-01)

Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination
by: Miao Wang, et al.
Published: (2023-12-01)

Function and structure of broadly neutralizing antibodies against SARS-CoV-2 Omicron variants isolated from prototype strain infected convalescents
by: Dan Li, et al.
Published: (2025-02-01)

In vitro expression of SARS coronavirus (SARS-CoV) nucleocapsid protein and examination of the function of monoclonal antibody induced by the expressed protein
by: CHEN Hong-xun, et al.
Published: (2005-03-01)

Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population
by: Zhigang Yi, et al.
Published: (2020-01-01)

Association Between COVID-19 and ABO Blood Groups: An Analysis on Convalescent Plasma Donors in Turkey
by: Mustafa Yilmaz, et al.
Published: (2021-06-01)

Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.
by: Carlo J Iasella, et al.
Published: (2024-01-01)

Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants
by: Frédéric Coutant, et al.
Published: (2024-12-01)

SARS-CoV-2-Neutralizing Antibodies
by: Yawen Liu, et al.
Published: (2024-11-01)

Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses
by: Siyuan Sun, et al.
Published: (2025-03-01)

New Coronavirus COVID-19 (SARS-CoV-2)
by: O. V. Shamsheva
Published: (2020-03-01)

Novel coronavirus SARS-CoV-2 in the context of global epidemiology of coronavirus infections
by: M. V. Supotnitskiy
Published: (2020-06-01)

Effect of SARS-CoV-2 Infection on Selected Parameters of the Apelinergic System in Repeat Blood Donors
by: Marta Stanek, et al.
Published: (2024-11-01)

Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration
by: Wesley V Cain, et al.
Published: (2022-01-01)

Antibiotic-associated syndrome in SARS-CoV-2 coronavirus infection
by: L. B. Golden, et al.
Published: (2023-01-01)

Serological insights into MERS-CoV dynamics of antibody responses during acute and convalescent phases and their clinical relevance for diagnostics and immunity
by: Khalid J. Shrwani, et al.
Published: (2025-09-01)

Convalescent plasma therapy in severe coronavirus disease-2019: A narrative review
by: Rasmi Ranjan Sahoo, et al.
Published: (2020-01-01)

Convalescent plasma therapy for COVID-19 – Donor selection strategies and establishment of a plasma bank
by: Mikael Kajova, et al.
Published: (2024-12-01)

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.
by: Felicitas Ruiz, et al.
Published: (2024-10-01)

Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?
by: Mohammad Mamun Alam, et al.
Published: (2024-12-01)

Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
by: Jared Sheehan, et al.
Published: (2025-01-01)

Breakthroughs in SARS-CoV-2-monoclonal antibodies development
by: Yusuf Muhammed, et al.
Published: (2021-02-01)

SARS-CoV-2 Neutralizing Antibodies 2.0
by: Youchun Wang
Published: (2024-11-01)

Male infertility along with the era of coronavirus infection SARS-CoV-2
by: N. G. Kulchenko, et al.
Published: (2022-12-01)

Correlations of interleukin levels with the severity of SARS-CoV-2 coronavirus infection
by: O. N. Yashkina, et al.
Published: (2023-04-01)

Mortality from Coronavirus (Covid) SARS-CoV-2 in Oncological Patients
by: Hoyos-Pulgarín, Julián Andrés, et al.
Published: (2025-04-01)